Barclays
INGN icon

Barclays’s Inogen INGN Stock Holding History

Barclays’s Portfolio INGN Stock Details INGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-10,000
Closed -$668K – 6900
2019
Q2 		$668K Buy
+10,000
New +$761K ﹤0.01% 4077
2018
Q1 		– Sell
-1,000
Closed -$119K – 7180
2017
Q4 		$119K Buy
+1,000
New +$110K ﹤0.01% 5106
2017
Q2 		– Sell
-60,000
Closed -$4.65M – 6769
2017
Q1 		$4.65M Sell
60,000
-5,000
-8% -$346K 0.01% 1373
2016
Q4 		$4.37M Buy
+65,000
New +$4.01M ﹤0.01% 1483

Other funds holding INGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Barclays's INGN Position: Q2 2026 in Review

Barclays reduced its Inogen (INGN) stake by 1.1% in Q2 2026, selling an estimated $3.18K and leaving 42,607 shares worth $275K. The position accounts for ﹤0.01% of the portfolio, ranked #3536.

Barclays first reported a position in INGN in Q1 2014 and has held it in 50 quarters since. The position peaked at $3.79M in Q4 2015. 129 funds tracked by Wall St. Rank hold INGN as of Q2 2026.

  • Barclays held 42,607 shares of Inogen worth $275K as of Q2 2026.
  • Barclays sold 480 Inogen shares in Q2 2026, an estimated $3.18K.
  • Inogen made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3536 holding.
  • Barclays first reported a position in Inogen in Q1 2014 and has held it in 50 quarters since.
  • Barclays's Inogen position peaked at $3.79M in Q4 2015.
  • 129 funds tracked by Wall St. Rank held Inogen as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.